iwCLL 2019: Dr. Nicole Lamanna on biomarker testing for chronic lymphocytic leukemia (CLL) As the science of chronic lymphocytic leukemia has advanced, we have learned much more detailed information about its biology and... Details
iwCLL 2019: Dr. Anthony Mato on risk factors for tumor lysis syndrome in chronic lymphocytic leukemia (CLL) iwCLL 2019: Dr. Anthony Mato on risk factors for tumor lysis syndrome in chronic lymphocytic leukemia (CLL) ... Details
iwCLL 2019: Dr. Constantine Tam on clonal evolution in chronic lymphocytic leukemia (CLL) During iwCLL 2019, Dr. Constantine Tam gave us a look at how the genetics of CLL cells can change over... Details
ASH 2019: Dr. Constantine Tam Discusses Captivate Trial – Ibrutinib + Venetoclax in First-Line Treatment Dr. Constantine Tam’s ASH 2019 (Orlando) monologue informs us that the BTK inhibitor zanabrutinib, still in clinical trials, is more... Details
ASH 2019: Dr. Allan Discusses a New Bruton’s Tyrosine Kinase (BTK) Inhibitor Currently in Phase I Trials Science moves fast! Follow the evolution of the development of BTKis! At ASH 2019 Dr. John Allan discussed the advantages... Details
iwCLL 2019: Dr. Maloney on “Off the Shelf” CAR-T cells for Chronic Lymphocytic Leukemia (CLL) ASH 2019: Dr. David Maloney on CAR-T therapy in CLL (chronic lymphocytic leukemia)... Details
ASH 2019: Dr. David Maloney on CAR-T therapy in CLL (chronic lymphocytic leukemia) ASH 2019: Dr. David Maloney on CAR-T therapy in CLL (chronic lymphocytic leukemia)... Details
ASH 2019: Dr. Adrian Wiestner on Bispecific Antibodies for Treating CLL (chronic lymphocytic leukemia) Also during ASH 2019, Dr. Koffman interviewed Dr. Adrian Wiestner, who discussed bi-specific antibodies to improve the immune system in... Details
ASH 2019: Dr. Krish Patel on harnessing the Immune System in Chronic Lymphocytic Leukemia (CLL) and other Lymphomas using Bispecific Antibodies Dr. Brian Koffman interviewed Dr. Krish Patel at ASH 2019, about how our native immune system is excellent at controlling... Details
ASH 2019: Dr. Jennifer Brown on ATM gene variants in chronic lymphocytic leukemia (CLL) ASH 2019 - Does an inherited defect in the germline ATM tumor suppressor gene contribute to the development of CLL?... Details
